Study of antioxidant enzymes level and phagocytic activity in chronic liver disease patients.
Patients with chronic cholestasis, particularly those with associated cirrhosis, are susceptible to infectious complications. A predictable consequence of cholestasis is malabsorption of fat-soluble vitamins and free radical scavengers. On the other hand, it has been postulated that cholestasis affects polymorphonuclear leukocytes function by impeding chemotaxis, phagocytosis and superoxide anion release in experimental animals. This work is aimed to evaluate the antioxidant status and phagocytic activity of neutrophils in chronic liver disease patients. 15 primary biliary cirrhosis (PBC) patients, 15 primary sclerosing cholangitis (PSC) patients, 15 chronic viral hepatitis C (HCV) patients, and 15 healthy individuals (control group) were included in this study. Levels of catalase (Cat), superoxide dismutase (SOD), reduced glutathione (GSH), glutathione peroxidase (GPx) and malondialdehyde (MDA) were assessed in both serum and neutrophils homogenates. Neutrophils function was estimated by nitroblue tetrazolium (NBT) reduction assay. A marked decrease in the antioxidant status was observed in serum and neutrophils' homogenate of patients with chronic liver diseases compared to healthy subjects. Significant elevation of lipid peroxides was found in all groups of liver disease patients. The majority of patients had reduced value in NBT reduction assay, which suggested a lack of response to infection by neutrophils. In conclusion, deficient antioxidant defense mechanisms may lead to excess oxygen free radicals formation that promote the pathological process in the liver. The use of free radicals scavengers by chronic liver patients may potentiate the antioxidant defense system against oxidative stress.
Salem
T A
TA
Genetic Engineering and Biotechnology Institute, National Liver Institute, Menoufiya University, Egypt.
El-Refaei
M F
MF
Badra
G A
GA
D000328:Adult; D000368:Aged; D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D016022:Case-Control Studies; D015209:Cholangitis, Sclerosing / Q000201:enzymology / Q000276:immunology; D002908:Chronic Disease; D005260:Female; D019698:Hepatitis C, Chronic / Q000201:enzymology / Q000276:immunology; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000201:enzymology / Q000276:immunology; D008107:Liver Diseases / Q000201:enzymology* / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology / Q000276:immunology; D010587:Phagocytosis
D000975:Antioxidants